nach oben

Journal of Neuro-Oncology

Erschienen in:

01.09.2008 | Invited Manuscript

Surgical management of newly diagnosed glioblastoma in adults: role of cytoreductive surgery

verfasst von: Timothy C. Ryken, Bruce Frankel, Terrance Julien, Jeffrey J. Olson

Erschienen in: Journal of Neuro-Oncology | Ausgabe 3/2008

Einloggen, um Zugang zu erhalten

Excerpt

There is insufficient evidence to support a Level I Recommendation. …

Bennett H, Godlee R (1888) Excision of a tumour from the brain. Lancet 2:906

Lacroix M, Abi-Said D, Fourney DR et al (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95(2):190–198PubMed

Hess KR (1999) Extent of resection as a prognostic variable in the treatment of gliomas. J Neurooncol 42(3):227–231PubMedCrossRef

Jackson RJ, Fuller GN, Abi-Said D et al (2001) Limitations of stereotactic biopsy in the initial management of gliomas. Neuro-oncology 3(3):193–200PubMedCrossRef

Yoshida T, Kawano N, Oka H, Fujii K, Nakazato Y (2000) Clinical cure of glioblastoma—two case reports. Neurol Med Chir (Tokyo) 40(4):224–229CrossRef

Bucy PC, Oberhill HR, Siqueira EB, Zimmerman HM, Jelsma RK (1985) Cerebral glioblastomas can be cured!. Neurosurgery 16(5):714–717PubMedCrossRef

Metcalfe SE (2000) Biopsy versus resection for malignant glioma. Cochrane Database Syst Rev 2:CD002034

Metcalfe SE, Grant R (2003) Biopsy versus resection for malignant glioma (Cochrane Review). The Cochrane Library

Nazzaro JM, Neuwelt EA (1990) The role of surgery in the management of supratentorial intermediate and high-grade astrocytomas in adults. J Neurosurg 73(3):331–344PubMed

10.

Vuorinen V, Hinkka S, Farkkila M, Jaaskelainen J (2003) Debulking or biopsy of malignant glioma in elderly people—a randomised study. Acta Neurochir (Wien) 145(1):5–10CrossRef

11.

Stummer W, Novotny A, Stepp H, Goetz C, Bise K, Reulen HJ (2000) Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg 93(6):1003–1013PubMed

12.

Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7(5):392–401PubMedCrossRef

13.

Slotman BJ, Kralendonk JH, van Alphen HA, Kamphorst W, Karim AB (1996) Hypofractionated radiation therapy in patients with glioblastoma multiforme: results of treatment and impact of prognostic factors. Int J Radiat Oncol Biol Phys 34(4):895–898PubMed

14.

Kiwit JC, Floeth FW, Bock WJ (1996) Survival in malignant glioma: analysis of prognostic factors with special regard to cytoreductive surgery. Zentralbl Neurochir 57(2):76–88PubMed

15.

Albert FK, Forsting M, Sartor K, Adams HP, Kunze S (1994) Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 34(1):45–60; discussion 60–41PubMedCrossRef

16.

Simpson JR, Horton J, Scott C et al (1993) Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int J Radiat Oncol Biol Phys 26(2):239–244PubMed

17.

Curran WJ Jr, Scott CB, Horton J et al (1992) Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trials. J Neurooncol 12(3):219–227PubMedCrossRef

18.

Bricolo A, Turazzi S, Cristofori L et al (1990) Experience in “radical” surgery of supratentorial gliomas in adults. J Neurosurg Sci 34(3–4):297–298PubMed

19.

Ammirati M, Vick N, Liao YL, Ciric I, Mikhael M (1987) Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas. Neurosurgery 21(2):201–206PubMedCrossRef

20.

Levin VA, Wara WM, Davis RL et al (1985) Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas. J Neurosurg 63(2):218–223PubMed

21.

Albert FK, Forsting M (2003) Resection and prognosis. J Neurosurg 98(1):225–226; author reply 226

22.

Silbergeld DL, Rostomily RC (2002) Resection of glioblastoma. J Neurosurg 96(4):809; author reply 810

23.

Stummer W, Steiger HJ (2002) Resection of glioblastoma. J Neurosurg 96(4):809–810; author reply 810

24.

Shinoda J, Sakai N, Murase S, Yano H, Matsuhisa T, Funakoshi T (2001) Selection of eligible patients with supratentorial glioblastoma multiforme for gross total resection. J Neurooncol 52(2):161–171PubMedCrossRef

25.

Keles GE, Anderson B, Berger MS (1999) The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere. Surg Neurol 52(4):371–379PubMedCrossRef

26.

Kreth FW, Berlis A, Spiropoulou V et al (1999) The role of tumor resection in the treatment of glioblastoma multiforme in adults. Cancer 86(10):2117–2123PubMedCrossRef

27.

Mohan DS, Suh JH, Phan JL, Kupelian PA, Cohen BH, Barnett GH (1998) Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution. Int J Radiat Oncol Biol Phys 42(5):981–987PubMed

28.

Kowalczuk A, Macdonald RL, Amidei C et al (1997) Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas. Neurosurgery 41(5):1028–1036; discussion 1036–1028PubMedCrossRef

29.

Nitta T, Sato K (1995) Prognostic implications of the extent of surgical resection in patients with intracranial malignant gliomas. Cancer 75(11):2727–2731PubMedCrossRef

30.

Obwegeser A, Ortler M, Seiwald M, Ulmer H, Kostron H (1995) Therapy of glioblastoma multiforme: a cumulative experience of 10 years. Acta Neurochir (Wien) 137(1–2):29–33CrossRef

31.

Quigley MR, Flores N, Maroon JC, Sargent B, Lang S, Elrifai A (1995) Value of surgical intervention in the treatment of glioma. Stereotact Funct Neurosurg 65(1–4):171–175PubMedCrossRef

32.

Jeremic B, Grujicic D, Antunovic V, Djuric L, Stojanovic M, Shibamoto Y (1994) Influence of extent of surgery and tumor location on treatment outcome of patients with glioblastoma multiforme treated with combined modality approach. J Neurooncol 21(2):177–185PubMedCrossRef

33.

Kelly PJ, Hunt C (1994) The limited value of cytoreductive surgery in elderly patients with malignant gliomas. Neurosurgery 34(1):62–66; discussion 66–67PubMedCrossRef

34.

Devaux BC, O’Fallon JR, Kelly PJ (1993) Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome. J Neurosurg 78(5):767–775PubMed

35.

Iacoangeli M, Roselli R, Prezioso A, Scerrati M, Rossi GF (1993) Staging of supratentorial hemispheric glioma using tumour extension, histopathological grade and extent of surgical resection. Br J Surg 80(9):1130–1133PubMedCrossRef

36.

Lai DM et al (1993) Therapy for supratentorial malignant astrocytomas: survival and possible prognostic factors. J Formos Med Assoc 92(3):220–226PubMed

37.

Kreth FW, Warnke PC, Scheremet R, Ostertag CB (1993) Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme. J Neurosurg 78(5):762–766PubMed

38.

Prados MD et al (1992) Highly anaplastic astrocytoma: a review of 357 patients treated between 1977 and 1989. Int J Radiat Oncol Biol Phys 23(1):3–8PubMed

39.

Vecht CJ, Avezaat CJ, van Putten WL, Eijkenboom WM, Stefanko SZ (1990) The influence of the extent of surgery on the neurological function and survival in malignant glioma. A retrospective analysis in 243 patients. J Neurol Neurosurg Psychiatry 53(6):466–471PubMedCrossRef

40.

Andreou J, George AE, Wise A et al (1983) CT prognostic criteria of survival after malignant glioma surgery. AJNR Am J Neuroradiol 4(3):488–490PubMed

41.

Ciric I et al (1987) Supratentorial gliomas: surgical considerations and immediate postoperative results. Gross total resection versus partial resection. Neurosurgery 21(1):21–26PubMedCrossRef

Titel: Surgical management of newly diagnosed glioblastoma in adults: role of cytoreductive surgery
verfasst von: Timothy C. Ryken
Bruce Frankel
Terrance Julien
Jeffrey J. Olson
Publikationsdatum: 01.09.2008
Verlag: Springer US
Erschienen in: Journal of Neuro-Oncology / Ausgabe 3/2008
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-008-9614-5

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2008

The emergence of clinical practice parameter guidelines in neuro-oncology: promise of utility tempered with caution

Radiation therapy of pathologically confirmed newly diagnosed glioblastoma in adults

Diagnosis of malignant glioma: role of neuropathology

Cytotoxic chemotherapeutic management of newly diagnosed glioblastoma multiforme

Guidelines for the treatment of newly diagnosed glioblastoma: introduction